Skip to main content

Latest SEC Filings — Page 166

Most recent SEC EDGAR filings across all covered tickers, sorted chronologically. Wiseek AI reads each filing and scores it 1–10 for market-moving potential; click through for full analysis.

How Wiseek curates this list

Every filing on this page is sourced directly from SEC EDGAR, the U.S. Securities and Exchange Commission's public filings system. Wiseek processes 8-K, 10-K, 10-Q, Form 4, Form 144, DEF 14A, Schedule 13D/A and related disclosures filed by U.S.-listed companies. The original filing is always linked from each article so readers can verify the source document directly.

How filings get scored

Each filing runs through Wiseek's importance scorer, which weights filing type, deal magnitude, insider participation, material-event flags (going-concern, restatements, executive transitions, M&A) and historical market-reaction patterns. Filings scoring below 7 on the 1–10 scale are filtered out at the database query so this list stays focused on market-moving disclosures. See our methodology for the full rubric.

Editorial standards

Wiseek does not edit the underlying SEC filing. Plain-English summaries and key-event extractions are generated from the verified source text and clearly attributed as AI-generated. Wiseek does not provide investment advice — see our editorial policy for full standards on accuracy, source disclosure, and corrections.

Track by company

Follow all SEC filings for a specific company by visiting its ticker page: AAPL, MSFT, NVDA, TSLA, AMZN, GOOGL, META, JPM, V, UNH, XOM, AVGO, LLY, MA, COST, JNJ, PG, HD, ABBV, MRK, KO, NFLX, AMD, WMT, CVX, BAC — or browse all covered tickers.

Goldman Sachs Reports Strong Q1 Earnings with 24% EPS Growth and Increased Dividend
ProForm 10-QGS · Form 10-Q · 9d ago
FTAI Aviation Reports Strong Q1 2026 Results with 65% Revenue Growth and Expanded Credit Facility
ProForm 10-QFTAI · Form 10-Q · 9d ago
Hemab Therapeutics Finalizes $301.5M Upsized Initial Public Offering to Advance Clinical Pipeline
ProForm 424B4COAG · Form 424B4 · 9d ago
Samsara Inc. Stockholders Approve Reincorporation from Delaware to Nevada
Form 8-KIOT · Form 8-K · 9d ago
Wabash National Reports Significant Q1 Loss, Deteriorating Operations, and Reduced Liquidity
ProForm 10-QWNC · Form 10-Q · 9d ago
Independent Bank Corp. Authorizes New $200 Million Share Repurchase Program
ProForm 8-KINDB · Form 8-K · 9d ago
Samsara Reincorporates to Nevada, Citing Delaware's Litigious Environment and Seeking Enhanced D&O Protections
ProForm PRE 14CIOT · Form PRE 14C · 9d ago
Agnico Eagle Reports Record Q1 Adjusted Net Income, Boosts Share Buyback Program to $2 Billion
ProForm 6-KAEM · Form 6-K · 9d ago
Twilio Reports Strong Q1 2026 Revenue and Profit Growth, Continues Share Repurchase Program
Form 10-QTWLO · Form 10-Q · 9d ago
Republic Airways Reports Strong Q1 Revenue Growth Post-Mesa Merger, Settles All Treasury Warrants
Form 10-QRJET · Form 10-Q · 9d ago
Sprinklr to Hold Annual Meeting, Limits Future Dilution by Foregoing Share Pool Increases
Form DEF 14ACXM · Form DEF 14A · 9d ago
La Rosa Holdings Clarifies Financial Restatement Details, No Impact on Gross Profit
Form 8-K/ALRHC · Form 8-K/A · 9d ago
Healthcare Realty Trust Reports Strong Q1 Financial Turnaround, Significant Share Buyback, and Improved Liquidity
ProForm 10-QHR · Form 10-Q · 9d ago
Bleichroeder Acquisition Corp. II Announces CEO Transition; Gundlach Becomes Executive Chairman, Padula Appointed CEO
Form 8-KBBCQ · Form 8-K · 9d ago
Moderna Reports Q1 Loss Driven by $950M Litigation Settlement; Highlights Pipeline Progress
ProForm 10-QMRNA · Form 10-Q · 9d ago
Perpetuals.com Ltd Finalizes Share Issuance for Perpetual Markets Acquisition
Form 6-K/APDC · Form 6-K/A · 9d ago
CCSC Technology to Issue 6.3M Shares for AI Platform Acquisition, Valued at $3.8M
ProForm 6-KCCTG · Form 6-K · 9d ago
Amphenol Reports Strong Q1 Organic Growth, Details $290M China Tax Impact & CommScope Acquisition
Form 10-QAPH · Form 10-Q · 9d ago
Avalyn Pharma Finalizes Post-IPO Corporate Charter and Bylaws
Form 8-KAVLN · Form 8-K · 9d ago
Origin Materials Announces Plan to Dissolve and Liquidate, CEO Steps Down Amidst 59% Workforce Reduction
ProForm 8-KORGN · Form 8-K · 9d ago
IRADIMED Reports Strong Q1 Financials with Double-Digit Growth and Healthy Liquidity
ProForm 10-QIRMD · Form 10-Q · 9d ago
Eledon Pharmaceuticals Files $500M Universal Shelf, Updates $75M ATM Program
ProForm S-3ELDN · Form S-3 · 9d ago
Shareholders to Vote on New Investment Adviser and Board Following Failed Reorganization
ProForm PRE 14AMIN · Form PRE 14A · 9d ago
Third Party Pays $850K Legal Settlement for Context Therapeutics, Resolving Stockholder Lawsuit
Form 8-KCNTX · Form 8-K · 9d ago
Aon Reports Strong Q1 2026 Results with 27% EPS Growth and Significant Cash Flow Increase
ProForm 10-QAON · Form 10-Q · 9d ago
Senseonics Prices $80M Public Offering at Deep Discount, Addressing Going Concern Risk
ProForm 424B5SENS · Form 424B5 · 9d ago
Enterprise Financial Services Reports Mixed Q1 Results with Improved Asset Quality
Form 10-QEFSC · Form 10-Q · 9d ago
InspireMD Recalls CGuard Prime Delivery System, Withdraws 2026 Revenue Guidance Amidst Going Concern Warning
ProForm 8-KNSPR · Form 8-K · 9d ago
Atlassian Reports Strong Q3 Revenue Growth, Announces Major Restructuring for AI Focus, and Completes $1.5B Share Buyback
ProForm 10-QTEAM · Form 10-Q · 9d ago
Senti Biosciences Secures Up to $40M in Highly Dilutive Convertible Notes, Leading to Change of Control
ProForm 8-KSNTI · Form 8-K · 9d ago